QRT's inhibitory effect on the PI3K/Akt/mTOR pathway primarily involves the reduction of Akt phosphorylation, which consequently decreases mTOR activity, leading to lower cellular proliferation and increased apoptosis in cancer cells. This evidence concerns the gene AKT1 and cancer.